
Thomas Sweeney Heard
Examiner (ID: 15653, Phone: (571)272-2064 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1281 |
| Issued Applications | 710 |
| Pending Applications | 83 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18634925
[patent_doc_number] => 11759496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Compounds and pharmaceutical use thereof in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/099974
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 18677
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099974 | Compounds and pharmaceutical use thereof in the treatment of cancer | May 9, 2017 | Issued |
Array
(
[id] => 12030793
[patent_doc_number] => 20170320893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'NANNOCYSTIN PROCESS AND PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 15/590804
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12895
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590804 | Nannocystin process and products | May 8, 2017 | Issued |
Array
(
[id] => 16908091
[patent_doc_number] => 11040108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Amino acid- and peptide-steroid conjugates and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/097325
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 14215
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097325
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097325 | Amino acid- and peptide-steroid conjugates and use thereof | Apr 27, 2017 | Issued |
Array
(
[id] => 12125079
[patent_doc_number] => 20180008665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'METHODS OF TREATING AND PREVENTING GOUT AND LEAD NEPHROPATHY'
[patent_app_type] => utility
[patent_app_number] => 15/581439
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6412
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581439
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581439 | METHODS OF TREATING AND PREVENTING GOUT AND LEAD NEPHROPATHY | Apr 27, 2017 | Abandoned |
Array
(
[id] => 18575494
[patent_doc_number] => 11732008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Preparation of functional homocysteine residues in polypeptides and peptides
[patent_app_type] => utility
[patent_app_number] => 16/096951
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 15382
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096951 | Preparation of functional homocysteine residues in polypeptides and peptides | Apr 26, 2017 | Issued |
Array
(
[id] => 11986673
[patent_doc_number] => 20170290827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/488035
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108658
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 67
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488035
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488035 | INHIBITORS OF HEPATITIS C VIRUS | Apr 13, 2017 | Abandoned |
Array
(
[id] => 11977466
[patent_doc_number] => 20170281620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'CHEMICALLY AND METABOLICALLY STABLE DIPEPTIDE POSSESSING POTENT SODIUM CHANNEL BLOCKER ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/485361
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17181
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/485361 | CHEMICALLY AND METABOLICALLY STABLE DIPEPTIDE POSSESSING POTENT SODIUM CHANNEL BLOCKER ACTIVITY | Apr 11, 2017 | Abandoned |
Array
(
[id] => 13699901
[patent_doc_number] => 20170360905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Conjugated C1 Esterase Inhibitor and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 15/479139
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479139 | Conjugated C1 Esterase Inhibitor and Uses Thereof | Apr 3, 2017 | Pending |
Array
(
[id] => 14182803
[patent_doc_number] => 20190111106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => COMPOSITIONS FOR INHIBITING FORMATION OF AND/OR DISRUPTING BACTERIAL BIOFILMS AND METHODS OF USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/091046
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091046 | Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor | Apr 3, 2017 | Issued |
Array
(
[id] => 15556795
[patent_doc_number] => 20200062809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHOD FOR SEPARATING AND PURIFYING MUSSEL ADHESIVE PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/495446
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495446 | METHOD FOR SEPARATING AND PURIFYING MUSSEL ADHESIVE PROTEIN | Mar 19, 2017 | Abandoned |
Array
(
[id] => 16799068
[patent_doc_number] => 10993983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Cyclic peptide epitopes and small-molecule mimics for inducing autophagy
[patent_app_type] => utility
[patent_app_number] => 16/085913
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 49
[patent_no_of_words] => 25915
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085913 | Cyclic peptide epitopes and small-molecule mimics for inducing autophagy | Mar 16, 2017 | Issued |
Array
(
[id] => 15848175
[patent_doc_number] => 10639348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Peptides with anti-cancer activity
[patent_app_type] => utility
[patent_app_number] => 16/084927
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 47525
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 824
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084927 | Peptides with anti-cancer activity | Mar 14, 2017 | Issued |
Array
(
[id] => 14501227
[patent_doc_number] => 20190194268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => MULTIMERIC DEFENSIN PROTEINS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/083610
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083610 | MULTIMERIC DEFENSIN PROTEINS AND RELATED METHODS | Mar 9, 2017 | Abandoned |
Array
(
[id] => 14715543
[patent_doc_number] => 20190248835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => COMPOUND, PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL SOLUTION CONTAINING THE COMPOUND, A METHOD OF DETERMINING THE PRESENCE OF CANCER, A KIT FOR CANCER DETECTION, AND THE USE OF HYDROLYSIS OF THE COMPOUND FOR THE DETECTION OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/082032
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082032
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082032 | Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer | Mar 2, 2017 | Issued |
Array
(
[id] => 16262516
[patent_doc_number] => 10753944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Methods for covalently binding a cell surface protein and a ligand
[patent_app_type] => utility
[patent_app_number] => 16/081030
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 25026
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081030 | Methods for covalently binding a cell surface protein and a ligand | Feb 28, 2017 | Issued |
Array
(
[id] => 13926241
[patent_doc_number] => 20190046636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => Amino Acid and Peptide Conjugates and Conjugation Process
[patent_app_type] => utility
[patent_app_number] => 16/076912
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076912 | Amino acid and peptide conjugates and conjugation process | Feb 23, 2017 | Issued |
Array
(
[id] => 11668487
[patent_doc_number] => 20170157206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/439206
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19620
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/439206 | High purity oritavancin and method of producing same | Feb 21, 2017 | Issued |
Array
(
[id] => 11935175
[patent_doc_number] => 20170239323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'ORITAVANCIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/436391
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18548
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436391 | ORITAVANCIN FORMULATIONS | Feb 16, 2017 | Abandoned |
Array
(
[id] => 17490437
[patent_doc_number] => 11279726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Norbornene-based amphipathic compound and utilization thereof
[patent_app_type] => utility
[patent_app_number] => 16/480348
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 24
[patent_no_of_words] => 11013
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480348 | Norbornene-based amphipathic compound and utilization thereof | Feb 9, 2017 | Issued |
Array
(
[id] => 13867545
[patent_doc_number] => 20190030113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => DIPEPTIDYL ALDEHYDES FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/077030
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077030 | DIPEPTIDYL ALDEHYDES FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES | Feb 7, 2017 | Abandoned |